Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 370.70
+0.40 (0.11%)
Oct 1, 2026, 3:15 PM IST
Biocon Employees
Biocon had 16,447 employees as of March 31, 2026. The number of employees increased by 132 or 0.81% compared to the previous year.
Employees
16,447
Change
132
Growth
0.81%
Revenue / Employee
10.53M INR
Profits / Employee
301.15K INR
Market Cap
603.61B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 16,447 | 132 | 0.81% |
| Mar 31, 2024 | 16,315 | -230 | -1.39% |
| Mar 31, 2023 | 16,545 | 1,545 | 10.30% |
| Mar 31, 2022 | 15,000 | 1,500 | 11.11% |
| Mar 31, 2021 | 13,500 | 891 | 7.07% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Anthem Biosciences | 2,282 |
| Panacea Biotec | 2,102 |
| OneSource Specialty Pharma | 1,674 |
| Concord Biotech | 1,624 |
| Dishman Carbogen Amcis | 934 |
| Lyka Labs | 648 |
| Zota Health Care | 635 |
| Haleos Labs | 611 |
Biocon News
- 9 days ago - Biocon's Pertuzumab Biosimilar Receives Positive EMA CHMP Recommendation - Nasdaq
- 24 days ago - Biocon Signs Brazil Pertuzumab Deal With Bahiafarma And Bionovis - Nasdaq
- 4 weeks ago - Don’t taunt me as billionaire: Kiran Mazumdar Shaw - The Times of India
- 1 month ago - Biocon Transcript: Q1 26/27 - Transcripts
- 1 month ago - Biocon Quarterly report: Q1 2027 - Filings
- 1 month ago - Biocon Slides: Q1 2027 - Filings
- 1 month ago - Biocon Q1 net profit surges fourfold to Rs 141 cr - The Times of India
- 1 month ago - India's Biocon posts more than fourfold jump in quarterly profit on strong biosimilars growth - Reuters